Hackensack Meridian Hackensack University and Jersey Shore University Medical Centers Providing Novel Irregular Heart Rhythm Treatment

Hackensack Meridian Hackensack University Medical Center and Hackensack Meridian Jersey Shore University Medical Center cardiologists have treated their first patients this week with the Medtronic PulseSelect Pulsed Field Ablation (PFA) System.

Cedars-Sinai Physician-Scientist Leads Association of American Physicians

Paul Noble, MD, professor of Medicine at Cedars-Sinai and a leading physician-scientist in pulmonary fibrosis, recently began his one-year term as president of the highly regarded Association of American Physicians (AAP) at the group’s annual meeting in Chicago.

Posterior Wall Ablation Does Not Help Patients With Persistent Atrial Fibrillation

FOR IMMEDIATE RELEASE                  Contact:  Ilana Nikravesh                  Mount Sinai Press Office                  212-241-9200                   [email protected]   …

Heart of the Matter: Media Tipsheet From Smidt Heart Institute at Cedars-Sinai

Cardiologists and cardiac and vascular surgeons from the Smidt Heart Institute at Cedars-Sinai are available for interviews throughout February to discuss heart-related topics, including the latest advances in research and patient care.

Cedars-Sinai Uses AI to Identify People With Abnormal Heart Rhythms

Investigators from the Smidt Heart Institute at Cedars-Sinai found that an artificial intelligence (AI) algorithm can detect an abnormal heart rhythm in people not yet showing symptoms.

Cardiac Arrest: Hispanics, Latinos With Kidney Disease at High Risk

Hispanics and Latinos with chronic kidney disease are at significant risk for suffering from sudden cardiac arrest, according to a new study from the Smidt Heart Institute at Cedars-Sinai.

Dissolving cardiac device monitors, treats heart disease

Nearly 700,000 people in the United States die from heart disease every year, and one-third of those deaths result from complications in the first weeks or months following a traumatic heart-related event. To help prevent those deaths, researchers at Northwestern and George Washington (GW) universities have developed a new device to monitor and treat heart disease and dysfunction in the days, weeks or months following such events.

Chula’s AICute Innovation – An Assessment Tool for Ischemic Stroke Risk to Reduce Disability and Death

A research team from the Faculty of Medicine and Faculty of Engineering, Chulalongkorn University has jointly developed AICute, an innovative program to assess the chances of stroke caused by heart disease (Ischemic Stroke), aimed at helping hospitals that lack cardiologists to enhance the effectiveness of stroke treatment, reduce congestion in hospitals and medical schools.

Detection of left atrial mechanical dysfunction by measurement of left atrial reservoir strain improves stroke prediction in persons without a history of atrial fibrillation or stroke

A cohort study of more than 4,500 persons without a history of atrial fibrillation (AF) or stroke has found that measuring left atrial mechanical function can improve stroke prediction. The findings are published in Annals of Internal Medicine.

Cleveland Clinic Researchers Identify Diabetes Drug Metformin as Potential Atrial Fibrillation Treatment in Collaborative Research

Cleveland Clinic researchers have identified a common diabetes medication, metformin, as a possible treatment for atrial fibrillation.

The study, published in Cell Reports Medicine, built on ongoing collaborative Cleveland Clinic research to support further investigation into metformin as a drug repurposing candidate. Researchers used advanced computation and genetic sequencing to determine that metformin’s targets overlap significantly with genes dysregulated in atrial fibrillation.

AI-guided screening uses ECG data to detect a hidden risk factor for stroke

An AI-guided targeted screening strategy is effective in detecting new cases of atrial fibrillation that would not have come to attention in routine clinical care.
This strategy could reduce the number of undiagnosed cases of atrial fibrillation, and prevent stroke and death in millions of patients across the globe.

Early rhythm control associated with lower risk of cardiovascular complications compared to rate control in most AF patients

A cohort study of patients with atrial fibrillation (AF) and low risk for stroke has found that the use of early rhythm control therapy was associated with a lower risk of cardiovascular death, ischemic stroke, hospitalization for heart failure, or myocardial infarction compared to rate control therapy. The findings are published in Annals of Internal Medicine.

Heart rhythm disorders: Mayo Clinic Healthcare expert shares 5 things it’s important to know

World Heart Day is Sept. 29 – Heart rhythm disorders are one of the most common cardiac problems. Arrhythmias cause the heart to beat too fast, too slow, or irregularly. People can be born with them or develop them during their lives.

MedStar Health offers the first FDA approved treatment for long-standing, persistent atrial fibrillation

Two MedStar Health hospitals are now offering an FDA-approved treatment for patients who have had persistent atrial fibrillation for more than a year. The Hybrid AF™ Convergent Therapy is available both at MedStar Washington Hospital Center and MedStar Union Memorial Hospital in Baltimore.

Morristown Medical Center to Host 9th Annual Frontiers in Cardiovascular Disease Virtual Symposium

Atlantic Health System’s Morristown Medical Center, one of the nation’s leading heart hospitals, will host a virtual conference featuring some of the world’s most distinguished cardiovascular faculty, who will discuss the latest developments in heart disease. This program is cosponsored by the NJ Chapter of the American College of Cardiology.

Edoxaban May Be Effective Treatment for Atrial Fibrillation After Transcatheter Aortic Valve Replacement

Mount Sinai study is first to compare this anticoagulant with the standard of care in large randomized clinical trial

3D Electrocardiogram Might Detect Paroxysmal Atrial Fibrillation

Rockville, Md. (November 25, 2020)—Atrial fibrillation is the most frequent arrhythmia in both equine and human athletes. In this study, researchers investigated whether the arrhythmogenic substrate—the preexisting condition that causes arrhythmia—present between the episodes of paroxysmal atrial fibrillation (PAF) can…

Morristown Medical Center’s Dr. Stephen Winters Discusses What Everyone Should Know About Atrial Fibrillation

September is National Atrial Fibrillation Month, and Stephen L. Winters, MD, director of the Cardiac Rhythm Management Program, Gagnon Cardiovascular Institute, Atlantic Health System’s Morristown Medical Center, wants the public to know some surprising facts about this increasingly common heart condition.

CRF Will Hold Free Online Seminar on Heart Disease Warning Signs

The Cardiovascular Research Foundation (CRF) will hold a free online seminar, “Get Heart Smart,” on August 24 hosted by Drs. Nisha Jhalani and Ajay Kirtane, renowned academic cardiologists from NewYork-Presbyterian/Columbia University Irving Medical Center. The seminar, part of a series of “Mini Med Schools” conducted by the CRF Women’s Heart Health Initiative, will focus on common heart disease symptoms, when to talk to your doctor, and when to seek emergency care.

Critical Transition Theory Shows Flickering in Heart Before Atrial Fibrillation

Atrial fibrillation ranks among the most common heart conditions, and episodes are difficult to predict. Researchers have proposed a way to define cardiac state and have studied the dynamics before the cardiac rhythm changes from normal sinus to AF rhythm and vice versa. The work, appearing in Chaos and based on critical transition theory, looks to provide an early warning for those with paroxysmal atrial fibrillation with potential implications for future wearable devices.

Atomic Magnetometer Points to Better Picture of Heart Conductivity

Mapping the electrical conductivity of the heart would be a valuable tool in diagnosis and disease management, but doing so would require invasive procedures, which aren’t capable of directly mapping dielectric properties. Significant advances have recently been made that leverage atomic magnetometers to provide a direct picture of electric conductivity of biological tissues, and in Applied Physics Letters, new work in quantum sensors points to ways such technology could be used to examine the heart.

New evidence supports ablation for heart failure patients with atrial fibrillation

Only 1 in 13 everyday patients could have participated in a pivotal international clinical trial looking at the use of catheter ablation to treat atrial fibrillation (AFib) among people with heart failure. However, new Mayo Clinic research provides evidence supporting the benefit of ablation, and shows what the outcomes might be for everyday patients. The Mayo study will be published in Heart Rhythm Journal.

Michigan hospital improves post-CABG outcomes, using proactive amiodarone protocol

A quality improvement project at Beaumont Hospital in Michigan resulted in a decreased incidence of postoperative atrial fibrillation and shorter mean lengths of stay. The results indicate that an amiodarone POAF prophylaxis protocol could significantly reduce costs, improve patient outcomes and increase the overall quality of care.

Skin-Cells-Turned-to-Heart-Cells Help Unravel Genetic Underpinnings of Cardiac Function

A small genetic study, published September 30, 2019 in Nature Genetics, identified a protein linked to many genetic variants that affect heart function. Researchers are expanding the model to other organ systems and at larger scales to create a broader understanding of genes and proteins involved.